C
China Dasheng Biotechnology Co
OTC:CDBT
China Dasheng Biotechnology Co
OTC:CDBT
Price:
0.0424
USD
37.22%
Market Cap:
$1.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
China Dasheng Biotechnology Co
Cash Equivalents
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
China Dasheng Biotechnology Co
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China Dasheng Biotechnology Co
OTC:CDBT
|
Cash Equivalents
$1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Cash Equivalents
$207.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
0%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Cash Equivalents
$715m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Cash Equivalents
$646.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
21%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Cash Equivalents
$2.2B
|
CAGR 3-Years
25%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Albemarle Corp
NYSE:ALB
|
Cash Equivalents
$1.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
|
No Stocks Found
China Dasheng Biotechnology Co
Glance View
China Dasheng Biotechnology Co. engages in the development, manufacture and sale of bacteria based products, which are used as additives for livestock feed and crop cultivation. The company is headquartered in Scottsdale, Arizona and currently employs 689 full-time employees. The company went IPO on 2008-02-13. The firm is not engaged in any business and has not generated any revenue.
CDBT
Intrinsic Value
Not Available
C
See Also
What is China Dasheng Biotechnology Co's Cash Equivalents?
Cash Equivalents
1.6m
USD
1.6m
USD
Based on the financial report for Jun 30, 2008, China Dasheng Biotechnology Co's Cash Equivalents amounts to 1.6m USD.
